IL58163A0 - 4-(2-benzoyloxy-3-tert-butylaminopropoxy)-2-methyl-indole its production and pharmaceutical compositions containing it - Google Patents

4-(2-benzoyloxy-3-tert-butylaminopropoxy)-2-methyl-indole its production and pharmaceutical compositions containing it

Info

Publication number
IL58163A0
IL58163A0 IL58163A IL5816379A IL58163A0 IL 58163 A0 IL58163 A0 IL 58163A0 IL 58163 A IL58163 A IL 58163A IL 5816379 A IL5816379 A IL 5816379A IL 58163 A0 IL58163 A0 IL 58163A0
Authority
IL
Israel
Prior art keywords
butylaminopropoxy
benzoyloxy
indole
tert
methyl
Prior art date
Application number
IL58163A
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL58163A0 publication Critical patent/IL58163A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
IL58163A 1975-08-15 1979-09-03 4-(2-benzoyloxy-3-tert-butylaminopropoxy)-2-methyl-indole its production and pharmaceutical compositions containing it IL58163A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1071475 1975-08-15

Publications (1)

Publication Number Publication Date
IL58163A0 true IL58163A0 (en) 1979-12-30

Family

ID=4366041

Family Applications (2)

Application Number Title Priority Date Filing Date
IL50263A IL50263A (en) 1975-08-15 1976-08-13 4-(2-benzoyloxy or phenoxyalkanoyl-oxy-3-tert-butylaminopropoxy)indole derivatives,their production and pharmaceutical compositions containing them
IL58163A IL58163A0 (en) 1975-08-15 1979-09-03 4-(2-benzoyloxy-3-tert-butylaminopropoxy)-2-methyl-indole its production and pharmaceutical compositions containing it

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL50263A IL50263A (en) 1975-08-15 1976-08-13 4-(2-benzoyloxy or phenoxyalkanoyl-oxy-3-tert-butylaminopropoxy)indole derivatives,their production and pharmaceutical compositions containing them

Country Status (28)

Country Link
US (1) US4434176A (en)
JP (2) JPS5223073A (en)
AT (1) AT363070B (en)
AU (1) AU505719B2 (en)
BE (1) BE845197R (en)
CA (1) CA1080720A (en)
CY (1) CY1225A (en)
DE (1) DE2635209C2 (en)
DK (1) DK152120C (en)
ES (1) ES450681A1 (en)
FI (1) FI63751C (en)
FR (1) FR2320743A2 (en)
GB (2) GB1575510A (en)
HK (1) HK35884A (en)
IE (1) IE43797B1 (en)
IL (2) IL50263A (en)
KE (1) KE3404A (en)
MY (1) MY8500135A (en)
NL (2) NL176362C (en)
NO (1) NO762735L (en)
NZ (1) NZ181764A (en)
PH (1) PH13356A (en)
PT (1) PT65477B (en)
SE (1) SE414633B (en)
SG (1) SG84883G (en)
SU (1) SU649313A3 (en)
YU (1) YU198876A (en)
ZA (1) ZA764883B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2830211A1 (en) * 1977-07-21 1979-02-01 Sandoz Ag SUBSTITUTED INDOL DERIVATIVES, THEIR PRODUCTION AND USE
JPS58106499A (en) * 1981-12-19 1983-06-24 株式会社東芝 Fuel exchanging device of fast breeder
HU196125B (en) * 1985-02-05 1988-10-28 Sandoz Ag Process for producing pharmaceutical comprising 3-(aminopropoxy)-indole derivatives combined with diuretic
US5174210A (en) * 1990-04-27 1992-12-29 Heidelberger Druckmaschinen Aktiengesellschaft Preparation of the inking unit of a printing press for a change of printing job
EP0750608A1 (en) * 1994-01-28 1997-01-02 Cal International Limited Pharmaceutical product comprising a salicylate of an esterifiable beta-blocker
EP2319843B1 (en) * 2003-05-30 2013-04-03 Ranbaxy Laboratories Limited Substituted pyrrole derivatives and their use as HMG-CO inhibitors
BRPI0618379A2 (en) * 2005-11-08 2011-08-30 Ranbaxy Lab Ltd (3r, 5r) -7- [2- (4-fluorophenyl) -5-isopropyl-3-phenyl-4 - [(4-hydroxymethylphenylamino) carbonyl] -pyrroleic acid 1-yl] -3,5-dihydroxy heptanoic
AR059838A1 (en) * 2006-03-14 2008-04-30 Ranbaxy Lab Ltd FORMULATIONS FOR STABILIZING DOSES OF STATIN
MX2009000439A (en) * 2006-07-14 2009-02-04 Ranbaxy Lab Ltd Polymorphic forms of an hmg-coa reductase inhibitor and uses thereof.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3751429A (en) * 1970-03-24 1973-08-07 Sandoz Ltd 4-(3-amino-2-substituted propoxy)indole derivatives
CH532040A (en) * 1970-03-24 1972-12-31 Sandoz Ag Process for the production of new indole derivatives
SE375771B (en) * 1970-09-30 1975-04-28 Sandoz Ag
CH545783A (en) * 1971-01-07 1974-02-15 Novel indole derivs - prepn by reacting 4-(2-hydroxy-3-isopropylaminopropoxy) indoles and acid anhy-drides
CH545784A (en) * 1971-01-07 1974-02-15 Beta blocking and anti-arrhythmic indole derivs - prepd by catalytic de-benzylation of 4-(3-benzyl aminopropoxy) indoles

Also Published As

Publication number Publication date
HK35884A (en) 1984-05-04
JPS5223073A (en) 1977-02-21
NL176362C (en) 1985-04-01
PH13356A (en) 1980-03-20
DE2635209A1 (en) 1977-02-24
IL50263A0 (en) 1976-10-31
GB1575509A (en) 1980-09-24
IE43797B1 (en) 1981-06-03
DK357576A (en) 1977-02-16
NL176362B (en) 1984-11-01
CY1225A (en) 1984-04-06
AT363070B (en) 1981-07-10
DE2635209C2 (en) 1983-01-27
JPS5649318A (en) 1981-05-02
JPS568834B2 (en) 1981-02-25
FI63751C (en) 1983-08-10
NO762735L (en) 1977-02-16
CA1080720A (en) 1980-07-01
SE7608865L (en) 1977-02-16
PT65477B (en) 1978-05-10
FI63751B (en) 1983-04-29
GB1575510A (en) 1980-09-24
SE414633B (en) 1980-08-11
DK152120C (en) 1988-06-20
FI762258A (en) 1977-02-16
AU1684176A (en) 1978-02-16
MY8500135A (en) 1985-12-31
NL7608902A (en) 1977-02-17
BE845197R (en) 1977-02-14
IE43797L (en) 1977-02-15
NL930134I1 (en) 1993-11-01
DK152120B (en) 1988-02-01
NL930134I2 (en) 1996-11-01
ATA602576A (en) 1980-12-15
SG84883G (en) 1985-01-11
IL50263A (en) 1980-06-30
PT65477A (en) 1976-09-01
SU649313A3 (en) 1979-02-25
US4434176A (en) 1984-02-28
NZ181764A (en) 1978-06-20
ZA764883B (en) 1978-03-29
FR2320743B2 (en) 1978-11-17
ES450681A1 (en) 1977-11-16
FR2320743A2 (en) 1977-03-11
AU505719B2 (en) 1979-11-29
YU198876A (en) 1982-05-31
KE3404A (en) 1985-02-01

Similar Documents

Publication Publication Date Title
IL50836A0 (en) Novel cyclopolypeptides their production and pharmaceutical compositions containing them
GB1524578A (en) Aminobenzoamide compounds and pharmaceutical compositions containing them
IL51087A0 (en) New polyhalogeno-steroids their manufacture and pharmaceutical compositions containing them
ZA763917B (en) Pharmaceutical compositions and compounds
IL51040A0 (en) Novel pyrimidone compounds and pharmaceutical compositions containing these
JPS5251367A (en) Production of novel substituted 44aminopyrazole and pharmaceutical agent containing the same
GB1537880A (en) 1-triarylalkyl-4-phenyl-4-piperidine-methanols and derivatives and pharmaceutical compositions containing them
CY1153A (en) Pharmaceutical compositions
NZ181503A (en) Substituted diphenyls-ulphides and pharmaceutical compositions
IL58163A0 (en) 4-(2-benzoyloxy-3-tert-butylaminopropoxy)-2-methyl-indole its production and pharmaceutical compositions containing it
NZ182591A (en) 14-substituted-daunorubicins and pharmaceutical compositions
IL50091A (en) 4-substituted-2-oxazolidinones,their production and pharmaceutical compositions containing them
IL50542A0 (en) Novel substituted pyridinecarboxamides their manufacture and pharmaceutical compositions containing them
NZ181864A (en) Noroxymorphones and pharmaceutical compositions
NZ182581A (en) -amino-ketones and pharmaceutical compositions
NZ181972A (en) N-aryl-n-(4-piperidyl)-arylacetamide derivatives and pharmaceutical compositions
PH13912A (en) Substituted benzamide derivatives and pharmaceutical compositions thereof
IL51016A0 (en) Novel acetamides their production and pharmaceutical compositions containing them
IL50198A0 (en) New morphanthridine derivatives their production and pharmaceutical compositions containing them
IL49124A0 (en) Novel d-homosteroids,their manufacture and pharmaceutical compositions containing them
KE3169A (en) Diphenylmethane derivatives and pharmaceutical compositions containing them
IL51104A0 (en) Novel isoquinoline derivatives their production and pharmaceutical compositions containing them
ZA761880B (en) New pharmaceutical compositions
IL53120A0 (en) Novel quinoline derivatives their production and pharmaceutical compositions containing them
GB1552416A (en) Pharmaceutical compositions